Non Peer-Reviewed Publications on Hazardous Drugs

The articles in this section, while not peer-reviewed, contain helpful “how-to” information for healthcare workers and others who work with antineoplastic and other hazardous drugs.  Many provide reference material and links to additional background information.

Aguero D and Marge K. Developing a USP <800> compliance gap analysis. Pharm Purch Prod. 2017; 14(1):10–12.

Berdi F, Powell MF, Sanz C, Gonzalez R and Massoomi F. Assessing the efficiency of CSTDs for compounding. Pharm Purch Prod. 2015; 12:4–7.

Berrios V, Smith D and Reichard JS. USP <800> compliance in outpatient infusion clinics. Pharm Purch Prod. 2017; 14(12):2–4.

Buckley B. When outsourcing IV drug preparation makes sense. Pharm Pract News. 2016; 43(7):36–38.

Buckley B. 10 Tips for building a compliant cleanroom. Pharm Pract News. 2016; 43(12):8–10.

Buckley B. USP <800> tips can be applied to home infusion. Pharm Pract News. 2017; 44(2):11–12.

Buckley B. On the bumpy road to USP <800> compliance: a tale of 3 hospitals. Pharm Pract News. 2017; 44(4):1, 26–27.

Buckley B. Pharm-entrepreneurs seek a better surface wipe. Pharm Pract News. 2017; 44(8):37–38.

Buckley B. USP hits pause on <800>, but no time to rest. Pharm Pract News. 2017; 44(11):1, 10–11.

Connor TH, Power LA, Massoomi F and Polovich M. Are gloves and gowns safe for handling chemotherapy? Pharm Purch Prod. 2015; 12:2–4.

Douglass K. Compliant garbing practices for sterile compounding. Pharm Purch Prod. 2016; 13(7):22–24.

Douglass K. Best practices for garbing in HD sterile compounding. Pharm Purch Prod. 2016; 13(11):56–64.

Douglass K. Best practices for sterile compounding. Pharm Purch Prod. 2017; 14(1):6–9.

Douglas K, Richter A, Dorey M and Rizvi I. Refining PPE usage for HD compounding: Part 1. Pharm Purch Prod. 2017; 14(2):18–21.

Eberwein SM and Amerine LB. Comparison of USP <800> gap analysis tools. Pharm Purch Prod. 2017; 14(4):12–13.

Eisenberg S. Hazardous drug handling in light of USP <800>. Pharm Purch Prod. 2015; 12(2):18–19.

Houchard G, Lewis P, Hymel L, Prenosil S and Kisgen R. A comprehensive approach to USP <800> compliance. Pharm Purch Prod. 2017; 14(11):20–31.

Jorgenson JA and Stevenson JG. Special report: closed-system drug-transfer devices: ONB classification and the draft NIOSH protocol. Pharm Pract News. 2017; Supp:1–4.

Karpinski J. 2016 Updates to the NIOSH hazardous drug list. Pharm Purch Prod. 2017; 14(7):36–38.

Kastango E. 5 Reasons why USP compliance matters now. Pharm Pract News. 2017; 44(9):18.

Kienle PC. Update on proposed USP Chapter <800>. Pharm Purch Prod. 2015; 12(2):2–4.

Kienle PC. Ensure USP <800> compliance beyond the pharmacy. Pharm Purch Prod. 2016; 13(9):2–4.

Kienle PC. Prepare for compliance: The Chapter <800> Answer Book. Pharm Purch Prod. 2017; 14(10):18–21.

Kienle P and Douglass K. Perform an assessment of risk to comply with USP <800>. Pharm Purch Prod. 2017; 14(3):26–31.

Krych RJ and Lupano C. USP-compliant outpatient center renovation. Part II. Pharm Purch Prod. 2017; 14(9):18–22.

Ledford A and Wetzel B. Constructing an oncology pharmacy. Pharm Purch Prod. 2017; 14(5):10–15.

Massoomi F. The evolution of the CSTD. Pharm Purch Prod. 2015; 12(2):S1–S12.

Massoomi F and Eisenberg S. Pharmacy and nursing collaborate on CSTD training. Pharm Purch Prod. 2015; 12(5):12–16.

Massoomi F and Kvancz DA. USP <800> requirements for engineering control. Pharm Purch Prod. 2016; 13(12):16–22.

Power LA and Polovich M. Safe handling of hazardous drugs: reviewing standards for worker protection. Pharm Pract News. 2016; Special Edition:23–36.

Rinehart JR and Jorgenson JA. Considerations for handling monoclonal antibodies. Pharm Purch Prod. 2015; 12(5):S6–S10.

Rosenthal M. CSTD buyers need advocacy help. Pharm Pract News. 2016; April 4, online issue.

Rosenthal M. Establishing procedures for testing CSTDs (Parts 1 and 2). Pharm Pract News. 2017; 44(3):32–33.

Shaw G. CSTDs should be at center of health care worker safety. Pharm Pract News. 2017; 44(12):1, 18–19.

Shaw G. Do you know what’s on the NIOSH HD list? Pharm Pract News. 2018; 45(1):16–17.

Wagner JT. Ensure safe use of CAIs and CACIs. Pharm Purch Prod. 2014; 11(12):12–14.